Mavens Biotech has informed about the details of voting results at the 33rd Annual General Meeting (AGM) of the Company held on September 28, 2015, under Clause 35A of Listing Agreement, along with Scrutinizer Report.
The above information is a part of company’s filings submitted to BSE.